Chaitra Gopalappa1, Stephanie L Sansom, Paul G Farnham, Yao-Hsuan Chen. 1. aDepartment of Mechanical and Industrial Engineering, Commonwealth Honors College, University of Massachusetts Amherst, Amherst, Massachusetts bDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
OBJECTIVE: Analyzing HIV care service targets for achieving a national goal of a 25% reduction in annual HIV incidence and evaluating the use of annual HIV diagnoses to measure progress in incidence reduction. DESIGN: Because there are considerable interactions among HIV care services, we model the dynamics of 'combinations' of increases in HIV care continuum targets to identify those that would achieve 25% reductions in annual incidence and diagnoses. METHODS: We used Progression and Transmission of HIV/AIDS 2.0, an agent-based dynamic stochastic simulation of HIV in the United States. RESULTS: A 25% reduction in annual incidence could be achieved by multiple alternative combinations of percentages of persons with diagnosed infection and persons with viral suppression including 85 and 68%, respectively, and 90 and 59%, respectively. The first combination corresponded to an 18% reduction in annual diagnoses, and infections being diagnosed at a median CD4 cell count of 372 cells/μl or approximately 3.8 years from time of infection. The corresponding values on the second combination are 4%, 462 cells/μl, and 2.0 years, respectively. CONCLUSION: Our analysis provides policy makers with specific targets and alternative choices to achieve the goal of a 25% reduction in HIV incidence. Reducing annual diagnoses does not equate to reducing annual incidence. Instead, progress toward reducing incidence can be measured by monitoring HIV surveillance data trends in CD4 cell count at diagnosis along with the proportion who have achieved viral suppression to determine where to focus local programmatic efforts.
OBJECTIVE: Analyzing HIV care service targets for achieving a national goal of a 25% reduction in annual HIV incidence and evaluating the use of annual HIV diagnoses to measure progress in incidence reduction. DESIGN: Because there are considerable interactions among HIV care services, we model the dynamics of 'combinations' of increases in HIV care continuum targets to identify those that would achieve 25% reductions in annual incidence and diagnoses. METHODS: We used Progression and Transmission of HIV/AIDS 2.0, an agent-based dynamic stochastic simulation of HIV in the United States. RESULTS: A 25% reduction in annual incidence could be achieved by multiple alternative combinations of percentages of persons with diagnosed infection and persons with viral suppression including 85 and 68%, respectively, and 90 and 59%, respectively. The first combination corresponded to an 18% reduction in annual diagnoses, and infections being diagnosed at a median CD4 cell count of 372 cells/μl or approximately 3.8 years from time of infection. The corresponding values on the second combination are 4%, 462 cells/μl, and 2.0 years, respectively. CONCLUSION: Our analysis provides policy makers with specific targets and alternative choices to achieve the goal of a 25% reduction in HIV incidence. Reducing annual diagnoses does not equate to reducing annual incidence. Instead, progress toward reducing incidence can be measured by monitoring HIV surveillance data trends in CD4 cell count at diagnosis along with the proportion who have achieved viral suppression to determine where to focus local programmatic efforts.
Authors: Sara Lodi; Andrew Phillips; Giota Touloumi; Ronald Geskus; Laurence Meyer; Rodolphe Thiébaut; Nikos Pantazis; Julia Del Amo; Anne M Johnson; Abdel Babiker; Kholoud Porter Journal: Clin Infect Dis Date: 2011-10 Impact factor: 9.079
Authors: Maunank Shah; Allison Perry; Kathryn Risher; Sunaina Kapoor; Jeremy Grey; Akshay Sharma; Eli S Rosenberg; Carlos Del Rio; Patrick Sullivan; David W Dowdy Journal: Lancet HIV Date: 2016-02-08 Impact factor: 12.767
Authors: Evin U Jacobson; Katherine A Hicks; Justin Carrico; David W Purcell; Timothy A Green; Jonathan H Mermin; Paul G Farnham Journal: J Acquir Immune Defic Syndr Date: 2022-04-01 Impact factor: 3.771
Authors: Davide Rasella; Gabriel Alves de Sampaio Morais; Rodrigo Volmir Anderle; Andréa Ferreira da Silva; Iracema Lua; Ronaldo Coelho; Felipe Alves Rubio; Laio Magno; Daiane Machado; Julia Pescarini; Luis Eugênio Souza; James Macinko; Inês Dourado Journal: PLoS One Date: 2022-03-22 Impact factor: 3.240